Vivos (RDGL) Notes Payables (2010 - 2023)
Vivos' (RDGL) quarterly Notes Payables came in at $10000.0 in Q3 2023, down 95.78% quarter-over-quarter from $237000.0 in Q3 2021.
Vivos (RDGL) Notes Payables (2010 - 2023) Analysis & Trends
Vivos has disclosed Notes Payables across 13 years of filings, most recently posting $10000.0 for Q3 2023.
- Notes Payables for Q3 2023 came in at $10000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2023 was $10000.0 (changed N/A YoY), and the FY2020 annual result was $237000.0, down 45.5% from the prior year.
- Notes Payables came in at $10000.0 for Q3 2023 at Vivos, down from $237000.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $434886.0 in Q4 2019 to a low of $10000.0 in Q3 2023.
- The 4-year median for Notes Payables is $237000.0 (2020), against an average of $178324.4.
- Peak annual rise in Notes Payables reached 707.98% in 2019, while the deepest fall reached 96.94% in 2019.
- Vivos' Notes Payables stood at $434886.0 in 2019, then plunged by 45.5% to $237000.0 in 2020, then changed by 0.0% to $237000.0 in 2021, then slumped by 95.78% to $10000.0 in 2023.
- The last three Notes Payables figures came in at $10000.0 (Q3 2023), $237000.0 (Q3 2021), and $237000.0 (Q2 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Vivos | - | - | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 10,000.00 |
| Sep 30, 2021 | 237,000.00 |
| Jun 30, 2021 | 237,000.00 |
| Mar 31, 2021 | 237,000.00 |
| Dec 31, 2020 | 237,000.00 |
| Sep 30, 2020 | 56,966.00 |
| Jun 30, 2020 | 237,000.00 |
| Dec 31, 2019 | 434,886.00 |
| Sep 30, 2019 | 100,000.00 |
| Jun 30, 2019 | 96,731.00 |
| Mar 31, 2019 | 77,985.00 |
| Dec 31, 2018 | 53,824.00 |
| Sep 30, 2018 | 32,279.00 |
| Jun 30, 2018 | 3.16 Mn |
| Mar 31, 2018 | 383,771.00 |
| Dec 31, 2017 | 383,771.00 |
| Sep 30, 2017 | 1.96 Mn |
| Jun 30, 2017 | 1.48 Mn |
| Mar 31, 2017 | 1.07 Mn |
| Dec 31, 2016 | 544,508.00 |